Citation: Se. Nadeau et al., REGIONAL-ANALYSIS OF D2 DOPAMINE-RECEPTORS IN PARKINSONS-DISEASE USING SPECT AND IODINE-123-IODOBENZAMIDE, The Journal of nuclear medicine, 36(3), 1995, pp. 384-393
Authors:
SWEET RA
POLLOCK BG
KIRSHNER M
WRIGHT B
ALTIERI LP
DEVANE CL
Citation: Ra. Sweet et al., PHARMACOKINETICS OF SINGLE-DOSE AND MULTIPLE-DOSE BUPROPION IN ELDERLY PATIENTS WITH DEPRESSION, Journal of clinical pharmacology, 35(9), 1995, pp. 876-884
Citation: Sc. Tyson et al., PHARMACOKINETIC INTERACTION BETWEEN RISPERIDONE AND CLOZAPINE, The American journal of psychiatry, 152(9), 1995, pp. 1401-1402
Authors:
SALHAB AS
DEVANE CL
MEDRANO T
BUHI WC
TEBBETT IR
SHIVERICK KT
Citation: As. Salhab et al., FETOPLACENTAL GROWTH AND PLACENTAL PROTEIN-SYNTHESIS IN RATS AFTER CHRONIC MATERNAL COCAINE ADMINISTRATION, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 392-398
Citation: Gm. Levin et Cl. Devane, PRESCRIBING ATTITUDES OF DIFFERENT PHYSICIAN GROUPS REGARDING FLUOXETINE, The Annals of pharmacotherapy, 27(12), 1993, pp. 1443-1447
Authors:
KEMPH JP
DEVANE CL
LEVIN GM
JARECKE R
MILLER RL
Citation: Jp. Kemph et al., TREATMENT OF AGGRESSIVE-CHILDREN WITH CLONIDINE - RESULTS OF AN OPEN PILOT-STUDY, Journal of the American Academy of Child and Adolescent Psychiatry, 32(3), 1993, pp. 577-581
Citation: Cl. Devane et al., EVALUATION OF POPULATION PHARMACOKINETICS IN THERAPEUTIC TRIALS .4. APPLICATION TO POSTMARKETING SURVEILLANCE, Clinical pharmacology and therapeutics, 53(5), 1993, pp. 521-528